Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Susannah J StanwayR Charles Coombes

Abstract

Inhibition of steroid sulfatase (STS), the enzyme responsible for the hydrolysis of steroid sulfates, represents a potential novel treatment for postmenopausal women with hormone-dependent breast cancer. Estrone and DHEA are formed by this sulfatase pathway and can be converted to steroids (estradiol and androstenediol, respectively), which have potent estrogenic properties. STX64 (667 Coumate), a tricylic coumarin-based sulfamate that irreversibly inhibits STS activity, was selected for entry into the first phase I trial of a STS inhibitor in postmenopausal women with breast cancer. STX64 was administered orally (nine patients at 5 mg and five patients at 20 mg) as an initial dose followed 1 week later by 3 x 2 weekly cycles, with each cycle comprising daily dosing for 5 days followed by 9 days off treatment. Blood and tumor tissue samples were collected for the assessment of STS activity and serum was obtained for steroid hormone measurements before and after treatment. The median inhibition of STS activity by STX64 was 98% in peripheral blood lymphocytes (PBL) and 99% in breast tumor tissue at the end of the 5-day dosing period. As expected, serum concentrations of estrone, estradiol, androstenediol, and DHEA all decreased s...Continue Reading

References

Aug 15, 1989·International Journal of Cancer. Journal International Du Cancer·M J ReedV H James
Apr 1, 1972·The Journal of Clinical Investigation·H J RuderM B Lipsett
Jan 1, 1982·British Journal of Cancer·R E TaylorR C Coombes
Jul 1, 1984·The Journal of Clinical Endocrinology and Metabolism·S J SantnerR J Santen
Sep 1, 1996·The Journal of Steroid Biochemistry and Molecular Biology·P K LiM E Rhodes
Aug 5, 2000·The Journal of Steroid Biochemistry and Molecular Biology·T UtsumiN Harada
Apr 3, 2001·The Journal of Steroid Biochemistry and Molecular Biology·B MaliniM J Reed
Aug 15, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E BajettaE Bombardieri
May 28, 2003·Biochemical and Biophysical Research Communications·Y T HoM J Reed
Jun 13, 2003·The New England Journal of Medicine·Ian E Smith, Mitch Dowsett
Aug 14, 2003·The Journal of Clinical Endocrinology and Metabolism·F PizzagalliM V St-Pierre
Mar 12, 2004·The New England Journal of Medicine·R Charles CoombesUNKNOWN Intergroup Exemestane Study
May 28, 2004·Endocrine-related Cancer·P E Lønning
Dec 2, 2004·The Journal of Clinical Endocrinology and Metabolism·Shuping WangRichard J Santen
Mar 1, 1993·Trends in Endocrinology and Metabolism : TEM·R Hobkirk
Apr 26, 2008·Endocrine Reviews·Stephanie T PageWilliam J Bremner

❮ Previous
Next ❯

Citations

Jan 16, 2013·International Journal of Colorectal Disease·Paul A Foster
Sep 18, 2007·Medical Molecular Morphology·Takashi SuzukiHironobu Sasano
Feb 3, 2007·Breast Cancer Research and Treatment·Louise M RasmussenAnne E Lykkesfeldt
Oct 16, 2007·Breast Cancer Research and Treatment·Ashok SubramanianKefah Mokbel
Mar 25, 2009·Breast Cancer Research and Treatment·Jiaqi FuMelissa Runge-Morris
Jul 16, 2008·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Takashi SuzukiHironobu Sasano
Dec 18, 2013·Chemical Reviews·William Spillane, Jean-Baptiste Malaubier
Mar 9, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roberta FerraldeschiGerhardt Attard
Aug 24, 2011·The Journal of Endocrinology·Atul Purohit, Paul A Foster
Sep 4, 2010·Drug Metabolism and Pharmacokinetics·Jun MatsumotoMitsukazu Kitada
Dec 3, 2013·Breast Cancer Research and Treatment·Toru HanamuraShin-ichi Hayashi
Nov 10, 2012·Expert Opinion on Therapeutic Patents·Spencer J Williams
Feb 24, 2011·Expert Review of Anticancer Therapy·Carlo PalmieriR Charles Coombes
Mar 1, 2016·Frontiers in Pharmacology·Tea Lanišnik Rižner
Sep 1, 2015·European Journal of Medicinal Chemistry·Saeed Emami, Sakineh Dadashpour
Jun 23, 2011·Molecular and Cellular Endocrinology·Atul PurohitBarry V L Potter
Apr 5, 2011·Steroids·René Maltais, Donald Poirier
Mar 2, 2011·The Journal of Steroid Biochemistry and Molecular Biology·Jürgen GeislerAtul Purohit
Jan 18, 2011·Molecular and Cellular Endocrinology·L W Lawrence WooBarry V L Potter
Nov 16, 2010·Molecular and Cellular Endocrinology·Takashi SuzukiHironobu Sasano
Nov 6, 2010·Bioorganic & Medicinal Chemistry Letters·Lisha YouYimin Li
Jun 30, 2009·Clinical Breast Cancer·Susan J CleatorCarlo Palmieri
Oct 25, 2008·Gynecologic Oncology·Justin C ChuraPeter A Argenta
Aug 30, 2008·Molecular and Cellular Endocrinology·Justin C ChuraPeter A Argenta
Jul 16, 2008·Current Opinion in Chemical Biology·Pavla Bojarová, Spencer J Williams
Oct 13, 2015·Molecular and Cellular Endocrinology·Robert ClarkeJ Michael Dixon
May 13, 2008·Best Practice & Research. Clinical Endocrinology & Metabolism·Elahe A Mostaghel, Peter S Nelson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Related Papers

Molecular and Cellular Endocrinology
Atul PurohitBarry V L Potter
The Journal of Steroid Biochemistry and Molecular Biology
Jürgen GeislerAtul Purohit
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Paul A FosterAtul Purohit
Medicinal Research Reviews
Peter Nussbaumer, Andreas Billich
© 2021 Meta ULC. All rights reserved